10x Genomics (TXG) reported 141.01millioninrevenueforthequarterendedMarch2024,representingayear−over−yearincreaseof50.50 for the same period compares to -0.44ayearago.ThereportedrevenuecomparestotheZacksConsensusEstimateof142.04 million, representing a surprise of -0.73%. The company delivered an EPS surprise of -8.70%, with the consensus EPS estimate being -$0.46.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- an ...